Month: April 2022

LAS VEGAS, April 12, 2022 (GLOBE NEWSWIRE) — MusclePharm Corporation (“MusclePharm” or the “Company”) (OTCMKTS: MSLP), a global provider of leading sports nutrition and lifestyle branded nutritional supplements, announced today that the Company will report its financial results for the fourth quarter and full year 2021 ended December 31, 2021, after the market closes on Thursday, April 14, 2022. The Company will host a conference call to discuss its operating results on Thursday, April 14, 2022, at 1:30 pm Pacific Time (4:30 pm Eastern Time). Investors interested in accessing the live call can dial (877) 407-0792 from the U.S. and International callers can dial (201) 689-8263. A telephone replay will be available following the event and can be accessed by dialing (844) 512-2921 from the U.S. and International callers can dial (412)...

Matthew Hagan Appointed Vice President, Marketing and Strategic Alliances David Lasecki Appointed Executive Director, Strategic Alliances FLORHAM PARK, N.J., April 12, 2022 (GLOBE NEWSWIRE) — Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery, development and commercialization of targeted drugs for the treatment of cancer, today announced the appointment of Matthew Hagan as vice president, marketing and strategic alliances and David Lasecki as executive director, strategic alliances. “Matt and David each bring a wealth of experience and strong track records of success in the launching and marketing of oncology therapeutics. Their respective understanding of the hematology market, key oncology delivery systems and relationships with hematology thought leadership will...

SOUTH SAN FRANCISCO, Calif., April 12, 2022 (GLOBE NEWSWIRE) — Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T™) products for cancer, today announced that management plans to participate in seven upcoming investor conferences. Canaccord Genuity Horizons in Oncology Virtual ConferenceThursday, April 14, 20228:00AM PT/11:00AM ET BofA Securities 2022 Healthcare ConferenceTuesday, May 10, 20228:00AM PT/11:00AM ET  2022 RBC Capital Markets Global Healthcare ConferenceTuesday, May 17, 20228:30AM PT/11:30AM ET Jefferies Global Healthcare ConferenceWednesday, June 8-Thursday, June 9, 2022Details to be posted to the Company’s website Goldman Sachs 43rd Annual Global Healthcare ConferenceMonday, June 13, 2022Details to be posted to the Company’s...

LONDON, April 12, 2022 (GLOBE NEWSWIRE) — Exela Technologies, Inc. (“Exela” or the “Company”) (NASDAQ: XELA), a global business process automation leader, today announced Exela has expanded its 30-year relationship with a tier one global bank by adding mobile payment processing. Our customer currently uses Exela for payments, fraud detection and mortgage processing. This multi-year XBP contract will be included in ITPS, Exela’s largest reporting segment. Exela’s exchange for bills and payment solutions can be deployed to bridge the gap between traditional and digital banking providing choice and scale. The mobile solution will fully manage mobile payments conforming to rules and best practices from Pay.UK, the UK’s primary payments body. “We are thankful to be selected and this also sets the stage for XBP solutions including Request...

LAWRENCEVILLE, N.J., April 12, 2022 (GLOBE NEWSWIRE) — Celsion Corporation (NASDAQ:CLSN), a clinical-stage company focused on DNA-based immunotherapy and next-generation vaccines, today announced it would highlight its PLACCINE platform technology in an oral presentation at the World Vaccine Congress taking place in Washington D.C. on April 18-21, 2022. Dr. Khursheed Anwar, Chief Scientific Officer at Celsion will present the Company’s technology platform during the Cancer and Immunotherapy session, in his presentation entitled: “Novel DNA Approaches for Cancer Immunotherapies and Multivalent Infectious Disease Vaccines.” Details of the presentation are as follows: Session: Cancer and Immunotherapy – M4Location: Liberty Salon I-KTitle: Novel DNA Approaches for Cancer Immunotherapies and Multivalent Infectious Disease VaccinesPresenter:...

Company’s Leadership to Host Corporate Update Via Audio Webcast Today at 4:30 PM ET WICHITA, Kan., April 12, 2022 (GLOBE NEWSWIRE) — AgEagle Aerial Systems Inc. (NYSE American: UAVS) (“AgEagle” or the “Company”), an industry-leading provider of full-stack drone, sensor and software solutions for commercial and government/defense use, today announced its financial results for the full year ended December 31, 2021. Financial Highlights for the Twelve Months Ended December 31, 2021 Compared to Prior YearTotal revenues rose 659% to $9.76 million from $1.29 million, due largely to revenue contributions from companies acquired by AgEagle during 2021, which included MicaSense, Measure Global and senseFly. Gross profit margin was 44% compared to 45%. Net loss available to common stockholders totaled $30.18 million, or $0.43 loss per...

BOSTON, April 12, 2022 (GLOBE NEWSWIRE) — Flywire Corporation (Nasdaq: FLYW) (“Flywire” or the “Company”) a global payments enablement and software company, today announced that it will host an Analyst Day on Thursday, May 19, 2022 in Boston, MA and virtually. The event will take place from 1:00pm ET to 5:00pm ET and will feature presentations and Q&A sessions with various members of Flywire’s management team. In-person attendance is limited. If you would like to attend in person, please contact flywireir@icrinc.com by April 19. The event will be webcast live from Flywire’s investor relations website at https://ir.flywire.com/. A replay of the event will be available on the investor relations website for one year following the presentations. About Flywire Flywire is a global payments enablement and software...

Sincerity Applied Materials Holdings Corp invites individual and institutional investors as well as advisors and analysts, to attend its real-time, interactive presentation at the Emerging Growth Conference MELBOURNE, Australia, April 12, 2022 (GLOBE NEWSWIRE) — Sincerity Applied Materials Holdings Corp (SINC), Applied Material Science (the “Company”) is pleased to announce that it has been invited to present at the Emerging Growth Conference on 9:30am – 10:00am, April 13, 2022. The next Emerging Growth Conference is presenting on 9:30am – 10:00am, April 13, 2022. This live, interactive online event will give existing shareholders and the investment community the opportunity to interact with the Company’s CEO, Yiwen (James) Zhang in real time. Mr. James Zhang will perform a presentation and may subsequently open the floor for questions....

This news release constitutes a “designated news release” for the purposes of the Company’s prospectus supplement dated May 11, 2021 to its short form base shelf prospectus dated May 7, 2021 and amended and restated on May 25, 2021. New debt financing arrangement will accelerate HEXO’s transformation into a cash flow positive business within the next four quarters HEXO and Tilray Brands to target combined cost-savings of up to U.S.$80M within 24 months to be realized from shared support services, commercial alliances and production efficiencies HEXO also enters into a definitive equity purchase agreement with an affiliate of KAOS Capital to establish C$180M backstop to reinvigorate its path forward growth strategy GATINEAU, Quebec, April 12, 2022 (GLOBE NEWSWIRE) — HEXO Corp. (TSX: HEXO; NASDAQ: HEXO) (“HEXO” or the...

  Marimekko Corporation, Stock Exchange Release, 12 April 2022 at 3.20 p.m. Resolutions of Marimekko Corporation’s Annual General Meeting and the Board of Directors’ constitutive meeting At Marimekko Corporation’s Annual General Meeting, held today, and at the subsequent constitutive meeting of the Board of Directors, the following resolutions were passed. A. RESOLUTIONS OF THE ANNUAL GENERAL MEETING Adoption of the financial statements Marimekko Corporation’s income statement and balance sheet and the consolidated income statement and balance sheet for 2021 were adopted. Payment of dividend The AGM approved the Board of Directors’ proposal to distribute a regular dividend of EUR 1.60 per share plus an extraordinary dividend of EUR 2.00 per share be paid for the financial year 2021, adding up to a total of EUR 3.60 per share. The dividend...